Buy Tamoxifen Online In Australia: What You Need To Know. Visit Our Pharmacy ↓

Tamoxifen in Australia: A Doctor’s Review for Women Over 30

Attention: If you or someone you love has been diagnosed with hormone receptor-positive breast cancer, ductal carcinoma in situ (DCIS), or is at high risk of breast cancer, you already know the fear: Will it come back? Will I be safe? What will treatment do to my body? For decades, one medicine has stood at the centre of Australian breast cancer care — tamoxifen. It is affordable, available on the PBS, and supported by some of the strongest evidence in oncology. Yet many women over 30 still feel unsure about it because they have heard frightening stories about hot flushes, blood clots, eye problems, and surgery risks. This review, written from a doctor’s viewpoint, will help you understand why tamoxifen remains a cornerstone treatment, what the real risks are, and how Australian women can use it safely and effectively.

Interest: What Is Tamoxifen and Why Does It Matter?

Tamoxifen is a selective oestrogen receptor modulator (SERM). In breast tissue, it blocks oestrogen from fuelling hormone-sensitive cancer cells. In Australia, it is used mainly for:

• Early-stage, hormone receptor-positive breast cancer in pre- and post-menopausal women
• Ductal carcinoma in situ (DCIS) after surgery to reduce recurrence
• Risk reduction in women at high risk of developing breast cancer
• Some advanced or metastatic breast cancers

What Are the SOFT and TEXT Trials About Tamoxifen?

Many Australian women ask about the SOFT and TEXT trials because these studies changed how we use tamoxifen in younger women. Both were international randomised controlled trials with Australian participation through Breast Cancer Trials (BCT) and the Australia and New Zealand Breast Cancer Trials Group (ANZBCTG).

Table 1: SOFT and TEXT trial summary

Trial	Who was studied	Comparison	Key finding for tamoxifen
SOFT (Suppression of Ovarian Function Trial)	Premenopausal women with hormone receptor-positive early breast cancer	Tamoxifen alone vs tamoxifen + ovarian suppression vs exemestane + ovarian suppression	Tamoxifen alone remains an effective option for many lower-risk women; adding ovarian suppression or switching to an aromatase inhibitor may benefit higher-risk women, especially after chemotherapy.
TEXT (Tamoxifen and Exemestane Trial)	Premenopausal women with hormone receptor-positive early breast cancer	Tamoxifen + ovarian suppression vs exemestane + ovarian suppression	Exemestane plus ovarian suppression improved disease-free survival, but tamoxifen plus ovarian suppression is still a standard choice for women who cannot take aromatase inhibitors or who prefer a well-established option.

Doctor’s perspective: These trials do not mean tamoxifen is outdated. They mean tamoxifen can be tailored. For many Australian women over 30 with lower-risk disease, tamoxifen alone is still an excellent, proven choice with fewer side effects than ovarian suppression or aromatase inhibitors.

What Are the Clinical Trials for Tamoxifen in Australia?

Australian researchers have contributed to major tamoxifen trials for decades. The IBIS-I and IBIS-II prevention trials included Australian sites and helped confirm tamoxifen’s role in reducing breast cancer risk in high-risk women. Australian centres also participated in the ATAC trial comparing tamoxifen with anastrozole, and in SOFT/TEXT. Currently, Breast Cancer Trials (BCT) continues to run endocrine therapy studies across Australia and New Zealand, giving patients access to new combinations and durations of tamoxifen. If you are interested in clinical trials, ask your oncologist or visit the Breast Cancer Trials website for open studies.

Desire: Addressing Your Real Fears and Pain Points

What Should I Discuss with My Doctor Before Starting Tamoxifen?

This is one of the most important conversations you can have. Before starting tamoxifen, tell your doctor about:

• Any personal or family history of blood clots (deep vein thrombosis or pulmonary embolism)
• Pregnancy or plans to become pregnant — tamoxifen can harm an unborn baby
• Breastfeeding
• Liver disease or abnormal liver function
• Any unusual vaginal bleeding or a history of uterine cancer or endometrial hyperplasia
• Eye problems such as cataracts or retinopathy
• All medicines, including herbal products, especially blood thinners, antidepressants, and hormone replacement therapy

Having these discussions reduces fear because it means your doctor can monitor you properly and pick the right dose and duration for your individual risk.

Is Tamoxifen Used for Ovarian Cancer?

Tamoxifen is not a first-line treatment for ovarian cancer, but it is sometimes considered in selected cases. Some recurrent or low-grade ovarian cancers express hormone receptors, and tamoxifen has been used off-label as a low-toxicity hormonal option after other treatments have stopped working. If you have ovarian cancer, do not start tamoxifen without a thorough discussion with your gynaecological oncologist. For breast cancer prevention and treatment, however, tamoxifen does not increase the risk of ovarian cancer in a way that should stop you from using it when indicated.

Can Tamoxifen Cause Hot Flushes?

Yes, hot flushes are the most common side effect. Tamoxifen reduces oestrogen activity, which can trigger sudden feelings of heat, sweating, and flushing. This is especially frustrating for women who are already perimenopausal or postmenopausal. The good news: hot flushes often improve over time, and there are practical ways to manage them.

Table 2: Managing common tamoxifen side effects

Side effect	What you can do	When to see your doctor
Hot flushes and night sweats	Dress in layers, use a fan, avoid caffeine, alcohol and spicy foods, keep your bedroom cool, regular exercise	If flushes are severe or disrupt sleep — non-hormonal medicines like venlafaxine, gabapentin or oxybutynin may help
Vaginal dryness or discharge	Water-based lubricants, vaginal moisturisers	If you notice unusual bleeding or discharge — may need investigation
Joint pain or stiffness	Gentle exercise, physiotherapy, paracetamol	If pain limits daily activities — your doctor may adjust treatment

What Are the Signs of Deep Vein Thrombosis on Tamoxifen?

Tamoxifen slightly increases the risk of blood clots, especially in women over 60, those who smoke, are overweight, have a personal or family history of clots, or are having major surgery. You need to know the warning signs.

Table 3: Recognising blood clot symptoms

Condition	Symptoms — seek urgent medical care
Deep vein thrombosis (DVT)	Swelling in one leg or arm, pain or tenderness, warmth, redness or discolouration of the skin, a heavy ache in the calf or thigh
Pulmonary embolism (PE)	Sudden shortness of breath, sharp chest pain that worsens with breathing, coughing up blood, rapid heart rate, feeling faint or dizzy

If you develop any of these symptoms, go to an emergency department immediately. The risk is low for most women, but knowing the signs saves lives.

Do I Need Eye Exams While on Tamoxifen?

Yes, eye health should not be ignored. Tamoxifen can cause cataracts, corneal changes, and in rare cases retinopathy. Most eye problems are mild and reversible if caught early. Have a baseline eye examination before or shortly after starting tamoxifen, and then have an eye check if you notice any of the following:

• Blurred vision
• Difficulty seeing at night
• Floaters or flashes of light
• Loss of part of your visual field

Routine eye exams every 1–2 years are sensible for any woman over 30, but especially if you take tamoxifen long term.

Should Tamoxifen Be Stopped Before Surgery?

This is a common and valid concern. Because tamoxifen raises the risk of blood clots, many surgeons and oncologists recommend temporarily stopping tamoxifen before major surgery — especially orthopaedic, abdominal, or cancer surgery that requires you to be immobile for a while. The usual practice is to stop tamoxifen 2 to 4 weeks before elective major surgery and restart after you are mobile again and the risk of clotting has dropped. For minor procedures, such as dental work or small skin excisions, you usually do not need to stop. Never stop tamoxifen without first speaking to your surgeon and oncologist. A short interruption for surgery is safe for breast cancer outcomes and significantly reduces your clot risk.

Action: Take Control of Your Breast Health

Tamoxifen is not a one-size-fits-all medicine, but for thousands of Australian women over 30 it has been a life-saving, recurrence-reducing, PBS-subsidised treatment. The key to using it well is knowledge, monitoring, and open communication with your healthcare team.

What to do next:

1. Book an appointment with your GP or oncologist to discuss whether tamoxifen is appropriate for your diagnosis or risk profile.
2. Bring a list of your questions — including the ones in this article — and be honest about your concerns.
3. If tamoxifen is prescribed, take it exactly as directed, usually once daily for 5 to 10 years depending on your situation.
4. Attend regular follow-up appointments for breast checks, blood tests, and any recommended eye exams.
5. Know the red flags: leg swelling, sudden breathlessness, unusual vaginal bleeding, or vision changes — and act immediately.

You do not have to live in fear. Tamoxifen is one of the most studied, effective, and affordable medicines in Australian cancer care. If you are over 30 and facing a hormone receptor-positive breast cancer diagnosis, DCIS, or a high-risk family history, ask your doctor today whether tamoxifen belongs in your treatment plan. A simple conversation could be the step that protects your future.

Disclaimer: This article is for educational purposes only and does not replace individual medical advice. Tamoxifen is a prescription-only medicine in Australia. Always consult a qualified doctor before starting, stopping, or changing any treatment.

https://www.stgeorgeregion.com.au/wp-content/uploads/2020/08/css/amoxil.html
https://www.stgeorgeregion.com.au/wp-content/uploads/2020/08/css/androgel.html
https://www.stgeorgeregion.com.au/wp-content/uploads/2020/08/css/estradiol.html